keyword
https://read.qxmd.com/read/38611342/exploring-the-nutritional-and-bioactive-potential-of-olive-leaf-residues-a-focus-on-minerals-and-polyphenols-in-the-context-of-spain-s-olive-oil-production
#1
JOURNAL ARTICLE
Carolina L Ronca, Carmen Duque-Soto, Cristina Samaniego-Sánchez, María Encarnación Morales-Hernández, Manuel Olalla-Herrera, Jesús Lozano-Sánchez, Rafael Giménez Martínez
Lyophilized plant-origin extracts are rich in highly potent antioxidant polyphenols. In order to incorporate them into food products, it is necessary to protect these phytochemicals from atmospheric factors such as heat, light, moisture, or pH, and to enhance their bioavailability due to their low solubility. To address these challenges, recent studies have focused on the development of encapsulation techniques for antioxidant compounds within polymeric structures. In this study, lyophilized olive leaf extracts were microencapsulated with the aim of overcoming the aforementioned challenges...
March 28, 2024: Foods (Basel, Switzerland)
https://read.qxmd.com/read/38565037/comparative-assessment-of-chondral-defect-repair-using-migratory-chondroprogenitors-suspended-in-either-gelled-or-freeze-dried-platelet-rich-plasma-an-in-vitro-and-ex-vivo-human-osteochondral-unit-model-study
#2
JOURNAL ARTICLE
Jeya Lisha J, Ganesh Parasuraman, Soosai Manickam Amirtham, Deepak Vinod Francis, Abel Livingston, Anjali Goyal, Boopalan Ramasamy, Solomon Sathishkumar, Elizabeth Vinod
BACKGROUND: Chondroprogenitors, with enhanced chondrogenic potential, have emerged to be a promising alternative for cell-based therapy in cartilage repair. Platelet-rich plasma (PRP), widely used for intra-articular treatment, has a short half-life. Freeze-dried PRP (FD-PRP), with an extended half-life and retained growth factors, is gaining attention. This study compares the efficacy of Migratory Chondroprogenitors (MCPs) in gelled PRP and FD-PRP using in-vitro and ex-vivo models, assessing FD-PRP as a potential off-the-shelf option for effective cartilage repair...
April 1, 2024: Knee
https://read.qxmd.com/read/38537745/young-human-plasma-derived-extracellular-vesicles-rescue-and-reactivate-il-1%C3%AE-and-tnf-%C3%AE-treated-chondrocytes
#3
JOURNAL ARTICLE
Rongjie Wu, Yu Xie, Yujie Peng, Xiaohu Wu, Yuanchen Ma, Feng-Juan Lyu, Qiujian Zheng, Zhantao Deng
Osteoarthritis (OA) is a degenerative disease that affects millions of individuals worldwide. Despite its prevalence, the exact causes and mechanisms behind OA are still not fully understood, resulting in a lack of effective treatments to slow down or halt disease progression. Recent research has discovered that extracellular vesicles (EVs) present in the circulation of young mice have a remarkable ability to activate musculoskeletal stem cells in elderly mice. Conversely, EVs derived from elderly mice do not exhibit the same potential, indicating that EVs obtained from young individuals may hold promise to activate aging cells in degenerative tissue...
March 25, 2024: Experimental Cell Research
https://read.qxmd.com/read/38485465/preparation-characterization-and-radiolabeling-of-anti-her2-scfv-with-technetium-tricarbonyl-and-stability-studies
#4
JOURNAL ARTICLE
Negar Bozorgchami, Maryam Ahmadzadeh, Dara Hatamabadi, Abdolreza Yazdani, Soraya Shahhosseini, Elham Mohit
Breast cancer is the most common diagnosed cancer, and the second cause of cancer death among women, worldwide. HER2 overexpression occurred in approximately 15% to 20% of breast cancers. Invasive biopsy method has been used for detection of HER2 overexpression. HER2-targeted imaging via an appropriate radionuclide is a promising method for sensitive and accurate identification of HER2+ primary and metastatic lesions. 99m Tc-anti-HER2 scFv can specifically target malignancies and be used for diagnosis of the cancer type and metastasis as well as treatment of breast cancer...
March 14, 2024: Journal of Labelled Compounds & Radiopharmaceuticals
https://read.qxmd.com/read/38458266/toward-the-boosted-loading-of-cisplatin-drug-into-liposome-nanocarriers
#5
JOURNAL ARTICLE
Anna M Wróblewska, Ewelina Łukawska, Zuzanna Wakuła, Joanna Zajda, Bernhard K Keppler, Andrei R Timerbaev, Magdalena Matczuk
Current challenges in oncology are largely associated with the need to improve the effectiveness of cancer treatment and to reduce drug's side effects. An effective strategy to cope with these challenges is behind designing and developing drug delivery systems based on smart nanomaterials and approved anticancer drugs. The present study offers a novel and straightforward approach to efficiently load the cisplatin drug into the newly constructed liposome-based nanosystems as well a reliable technique for monitoring this process based on capillary electrophoresis hyphenated with inductively coupled plasma tandem mass spectrometry...
March 6, 2024: European Journal of Pharmaceutics and Biopharmaceutics
https://read.qxmd.com/read/38362605/plasma-indications-controversies-and-opportunities
#6
REVIEW
Michael A Benson, Deborah Tolich, Jeannie L Callum, Moises Auron
Plasma is overused as a blood product worldwide; however, data supporting appropriate use of plasma is scant. Its most common utilization is for treatment of coagulopathy in actively bleeding patients; it is also used for coagulation optimization prior to procedures with specific coagulation profile targets. A baseline literature review in PUBMED and Google Scholar was done (1 January 2000 to 1 June 2023), utilizing the following search terms: plasma, fresh frozen plasma, lyophilized plasma, indications, massive transfusion protocol, liver disease, warfarin reversal, cardiothoracic surgery, INR < 2...
February 16, 2024: Postgraduate Medicine
https://read.qxmd.com/read/38358906/mixing-studies-for-lupus-anticoagulant-does-it-matter-how-we-mix
#7
JOURNAL ARTICLE
Vanja Radišić Biljak, Matea Tomas, Ivana Lapić
Although clear and detailed recommendation regarding the lupus anticoagulant mixing test exist, various sources of NPP are used. We decided to inspect the possible differences in mixing studies depending on the mixing media. Four types of mixing media were prepared for 45 random remnant plasma samples: standard human plasma, control plasma N, previously analyzed patient with normal coagulation values, and home-made normal pool plasma (NPP). Samples were analyzed by using Siemens Dade Actin FSL Activated PTT Reagent on BCS XP analyzer...
February 15, 2024: Blood Coagulation & Fibrinolysis: An International Journal in Haemostasis and Thrombosis
https://read.qxmd.com/read/38314241/implementation-of-a-bleeding-management-algorithm-in-liver-transplantation-a-pilot-study
#8
JOURNAL ARTICLE
Ignacio A Sarmiento, María F Guzmán, Javier Chapochnick, Jens Meier
OBJECTIVES: The aims of the study were to compare the consumption of blood products before and after the implementation of a bleeding management algorithm in patients undergoing liver transplantation and to determine the feasibility of a multicentre, randomized study. BACKGROUND: Liver transplantation remains the only curative therapy for patients with end-stage liver disease, but it carries a high risk of surgical bleeding. MATERIALS AND METHODS: Retrospective study of patients treated before (group 1) and after (group 2) implementation of a haemostatic algorithm guided by viscoelastic testing, including use of lyophilized coagulation factor concentrates ( prothrombin complex and fibrinogen concentrates )...
February 2024: Transfusion Medicine and Hemotherapy
https://read.qxmd.com/read/38311196/characterization-of-the-molecular-composition-and-in-vitro-regenerative-capacity-of-platelet-based-bioproducts-and-related-subfractions
#9
JOURNAL ARTICLE
Andrea Acebes-Huerta, Patricia Martínez-Botía, Graciela Carbajo-Argüelles, Judit Fernández-Fuertes, María Carmen Muñoz-Turrillas, Ana María Ojea-Pérez, Antonio Lopéz-Vázquez, Johannes A Eble, Laura Gutiérrez
The use and demand of platelet-based bioproducts in regenerative medicine is steadily increasing. However, it is very difficult to establish the real clinical benefits of these therapies, as the lack of characterization and detailed production methods of platelet-based bioproducts persists in the literature and precludes cross-study comparisons. We characterized the molecular composition and in vitro regenerative capacity of platelet-rich plasma (PRP) produced in a closed-system. Furthermore, we performed a parallel characterization on different PRP subfractions (plasma and plasma-free platelet lysate), identifying that the fractions containing platelet-derived cargo exert the most potent regenerative capacity...
February 2, 2024: Acta Biomaterialia
https://read.qxmd.com/read/38272856/the-future-of-blood-services-amid-a-tight-balance-between-the-supply-and-demand-of-blood-products-perspectives-from-the-isbt-young-professional-council
#10
JOURNAL ARTICLE
Antoine Lewin, Eunike McGowan, Jian Ou-Yang, Lilian Antwi Boateng, Carla Luana Dinardo, Saikat Mandal, Nour Almozain, Jannison Ribeiro, Syeldy Langi Sasongko
BACKGROUND AND OBJECTIVES: Blood services manage the increasingly tight balance between the supply and demand of blood products, and their role in health research is expanding. This review explores the themes that may define the future of blood banking. MATERIALS AND METHODS: We reviewed the PubMed database for articles on emerging/new blood-derived products and the utilization of blood donors in health research. RESULTS: In high-income countries (HICs), blood services may consider offering these products: whole blood, cold-stored platelets, synthetic blood components, convalescent plasma, lyophilized plasma and cryopreserved/lyophilized platelets...
January 25, 2024: Vox Sanguinis
https://read.qxmd.com/read/38166940/thrombolytic-therapy-based-on-lyophilized-platelet-derived-nanocarriers-for-ischemic-stroke
#11
JOURNAL ARTICLE
Martina Migliavacca, Clara Correa-Paz, María Pérez-Mato, Patrick-Brian Bielawski, Issan Zhang, Pauline Marie, Pablo Hervella, Marina Rubio, Dusica Maysinger, Denis Vivien, Pablo Del Pino, Beatriz Pelaz, Ester Polo, Francisco Campos
BACKGROUND: Intravenous administration of fibrinolytic drugs, such as recombinant tissue plasminogen activator (rtPA) is the standard treatment of acute thrombotic diseases. However, current fibrinolytics exhibit limited clinical efficacy because of their short plasma half-lives and risk of hemorrhagic transformations. Platelet membrane-based nanocarriers have received increasing attention for ischemic stroke therapies, as they have natural thrombus-targeting activity, can prolong half-life of the fibrinolytic therapy, and reduce side effects...
January 3, 2024: Journal of Nanobiotechnology
https://read.qxmd.com/read/38114340/prehospital-freeze-dried-plasma-in-trauma-a-critical-review
#12
REVIEW
William P Sheffield, Kanwal Singh, Andrew Beckett, Dana V Devine
Major traumatic hemorrhage is now frequently treated by early hemostatic resuscitation on hospital arrival. Prehospital hemostatic resuscitation could therefore improve outcomes for bleeding trauma patients, but there are logistical challenges. Freeze-dried plasma (FDP) offers indisputable logistical advantages over conventional blood products, such as long shelf life, stability at ambient temperature, and rapid reconstitution without specialized equipment. We sought high level, randomized, controlled evidence of FDP clinical efficacy in trauma...
January 2024: Transfusion Medicine Reviews
https://read.qxmd.com/read/38072965/single-protein-encapsulated-sn38-for-tumor-targeting-treatment
#13
JOURNAL ARTICLE
Changjun Yu, Faqing Huang, Kinsley Wang, Mengmeng Liu, Warren A Chow, Xiang Ling, Fengzhi Li, Jason L Causey, Xiuzhen Huang, Galen Cook-Wiens, Xiaojiang Cui
BACKGROUND: The alkaloid camptothecin analog SN38 is a potent antineoplastic agent, but cannot be used directly for clinical application due to its poor water solubility. Currently, the prodrug approach on SN38 has resulted in 3 FDA-approved cancer therapeutics, irinotecan, ONIVYDE, and Trodelvy. However, only 2-8% of irinotecan can be transformed enzymatically in vivo into the active metabolite SN38, which severely limits the drug's efficacy. While numerous drug delivery systems have been attempted to achieve effective SN38 delivery, none have produced drug products with antitumor efficacy better than irinotecan in clinical trials...
December 10, 2023: Journal of Translational Medicine
https://read.qxmd.com/read/38018260/new-plasma-protein-c-and-protein-s-concentrate-a-synergy-for-therapeutic-purposes
#14
JOURNAL ARTICLE
Filippo Mori, Cristina Angelini, Claudio Farina
BACKGROUND AND OBJECTIVES: Deficiencies of protein C (PC) or protein S (PS) are rare diseases, characterized by mutations in the PC or PS genes, which encode plasma serine proteases with anti-coagulant activity. Severe PC or PS deficiencies manifest in early life as neonatal purpura fulminans, a life-threatening heamorrhagic condition requiring immediate treatment. First-line treatment involves replacement therapy, followed by maintenance with anti-coagulants. Replacement therapy with specific protein concentrates is currently only limited to PC, and therefore, a PC + PS concentrate represents a useful addition to therapeutic options, particularly for severe PS deficiency...
November 28, 2023: Vox Sanguinis
https://read.qxmd.com/read/38011515/compact-point-of-care-device-for-self-administered-hiv-viral-load-tests-from-whole-blood
#15
JOURNAL ARTICLE
Tianyi Liu, Anthony J Politza, Aneesh Kshirsagar, Yusheng Zhu, Weihua Guan
Human immunodeficiency virus (HIV) is a significant problem to consider as it can lead to acquired immune deficiency syndrome (AIDS). Fortunately, AIDS is manageable through antiretroviral therapy (ART). However, frequent viral load monitoring is needed to monitor the effectiveness of the therapy. The current reverse transcription-polymerase chain reaction (RT-PCR) viral load monitoring is highly effective, but is challenged by being resource-intensive and inaccessible, and its turnaround time does not meet demand...
November 27, 2023: ACS Sensors
https://read.qxmd.com/read/37966879/in-vitro-evaluation-of-hyperosmotic-canine-plasma-suitable-for-infusion
#16
JOURNAL ARTICLE
Thomas H Edwards, Michael A Meledeo, Grantham C Peltier, Alice F Henderson, Luis A Pompa, James A Bynum
OBJECTIVE: To determine the characteristics of canine freeze-dried plasma (cFDP) as it is serially diluted with sterile water. DESIGN: In vitro experimental study. SETTING: Government blood and coagulation research laboratory. ANIMALS: cFDP from a commercial manufacturer. INTERVENTIONS: Ten units of cFDP were reconstituted to 100%, 90%, 80%, 70%, 60%, 50%, and 40% of the recommended volume with sterile water...
November 15, 2023: Journal of Veterinary Emergency and Critical Care
https://read.qxmd.com/read/37928064/platelet-rich-plasma-combined-with-lyophilizing-thrombin-powder-for-the-treatment-of-complicated-enterocutaneous-fistula-a-case-report
#17
Chao He, Kui Liu, Zhijie Zhao, Zhihao Lai, Linlin Qu
BACKGROUND: Enterocutaneous fistula is one of the most challenging problems facing surgeons. In severe cases, a large amount of fluid loss can lead to problems such as water and electrolyte acid-base imbalance, malnutrition, infection, and organ dysfunction. Here we reported a case of platelet-rich plasma combined with lyophilizing thrombin powder for the treatment of complicated enterocutaneous fistula. CASE PRESENTATION: A 48-year-old male, more than 2 years after the operation of abdominal trauma, the leakage of the fistula in the right upper abdominal wall was accompanied by fever for 3 days...
2023: Frontiers in Surgery
https://read.qxmd.com/read/37820944/research-on-the-preparation-process-of-the-cytarabine-daunorubicin-dual-encapsulation-liposome-and-its-physicochemical-properties-and-performances-in-vitro-vivo
#18
JOURNAL ARTICLE
Boyuan Liu, Jiaoyang Zhang, Zixu Liu, Ping Wang, Yu Zhang, Haibing He, Tian Yin, Jingxin Gou, Xing Tang
As the only Food and Drug Administration (FDA)-approved dual-encapsulation liposome injection for treating Acute myeloid leukemia (AML), CPX-351 outperforms the standard chemotherapy treatment "DA 7+3" in terms of clinical effectiveness. Although research on dual-loaded liposomes has increased in recent years, little attention has been paid to their preparation, which can affect their quality, efficacy, and safety. This study explored various preparation processes to create the cytarabine/daunorubicin co-loaded liposome (the Cyt/Daun liposome) and eventually settled on two methods: the sequential loading approach, thin film hydration-extrusion-copper ion gradient, and the simultaneous encapsulation technique, copper ion gradient-concentration gradient...
October 9, 2023: International Journal of Pharmaceutics
https://read.qxmd.com/read/37779081/celecoxib-loaded-self-micellizing-solid-dispersion-suppresses-its-delayed-absorption-in-rats-with-impaired-gastrointestinal-motility
#19
JOURNAL ARTICLE
Mizuki Ogino, Keisuke Yakushiji, Hiroki Suzuki, Yukinori Yamauchi, Yoshiki Seto, Hideyuki Sato, Satomi Onoue
The aim of this study was to develop a self-micellizing solid dispersion of celecoxib (SMSD/CEL) with enhanced dissolution to suppress a delay in absorption under impairment of gastrointestinal (GI) secretion and motility induced by severe pain. Soluplus® -based SMSD/CEL was prepared by lyophilization and physiochemically characterized. A pharmacokinetic study of orally-dosed CEL samples was carried out in rats with propantheline (PPT)-induced the impairment of GI secretion and motility. SMSD/CEL was micellized in aqueous media with a mean diameter of 153 nm, and it showed improved dissolution behavior of CEL under acidic conditions with 2...
2023: Chemical & Pharmaceutical Bulletin
https://read.qxmd.com/read/37734255/determination-of-plasma-concentration-of-belimumab-by-lc-ms-ms-method-development-validation-and-clinical-application
#20
JOURNAL ARTICLE
Clémence Marin, Gaëlle Noé, Dimitri Schlemmer, Quentin Beaulieu, Pascal Robidou, Bochra Mansour, Christophe Hirtz, Jérôme Vialaret, Marie Antignac, Quentin Moyon, Neila Benameur, Zahir Amoura, Noël Zahr
INTRODUCTION: Belimumab is a monoclonal antibody against B cell activating factor (BLyS). This monoclonal antibody (mAb) has been shown to be effective in reducing disease activity in patients with systemic lupus erythematosus (SLE). Belimumab is available in two forms as a lyophilized powder for intravenous (IV) use, or single-dose syringe for subcutaneous (SC) use. The aim of this study was to develop and validate a liquid chromatography-tandem mass spectrometry (LC-MS/MS) method for quantitation of belimumab in human serum...
September 17, 2023: Journal of Pharmaceutical and Biomedical Analysis
keyword
keyword
96011
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.